Microcalcification crystallography as a potential marker of DCIS recurrence

Microcalcification crystallography as a potential marker of DCIS recurrence

Abstract Ductal carcinoma in-situ (DCIS) accounts for 20–25% of all new breast cancer diagnoses. DCIS has an uncertain risk of progression to invasive breast cancer and a lack of predictive biomarkers may result in relatively high levels (~ 75%) of overtreatment. To identify unique prognostic biomar...

Full description

Bibliographic Details
Main Authors: Sarah B. Gosling, Emily L. Arnold, Samantha K. Davies, Hannah Cross, Ihssane Bouybayoune, Doriana Calabrese, Jayakrupakar Nallala, Sarah E. Pinder, Liping Fu, Esther H. Lips, Lorraine King, Jeffrey Marks, Allison Hall, Lars J. Grimm, Thomas Lynch, Donna Pinto, Hilary Stobart, E. Shelley Hwang, Jelle Wesseling, Kalotina Geraki, Nicholas Stone, Iain D. Lyburn, Charlene Greenwood, Keith D. Rogers, Grand Challenge PRECISION Consortium
Format: Article
Language:English
Published: Nature Portfolio 2023-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-33547-8

Internet

https://doi.org/10.1038/s41598-023-33547-8

Similar Items